A team led by University College London Institute of Neurology discovered ambroxol therapy could be used as a neuroprotective compound to treat patients with Parkinson’s disease both with and without glucocerebrosidase (GBA1) gene mutations. This study was sponsored...
Morton Plant Hospital in Clearwater, Florida in the Tampa Bay region has signed up to participate in a clinical trial evaluating novel Alzheimer’s disease detection method. The goal is to drastically impact the lives of thousands of people and family members dealing...
The University of Aberdeen, led by Zosia Miedzybrodzka, cares for Huntington’s disease (HD) patients, such as Sandy Patience of Scotland, as the 801 patient global study known as Generation-HD1 unfolds. Patience inherited this condition and declared the clinical...
The University of Rhode Island, Florida’s BayCare Health System, and the Memory and Aging Program at Butler Hospital are launching a clinical trial with profound implications: what if a standard eye examination inclusive of a retinal scan could detect biomarkers...
Unsuccessful drug trials, insufficient funding, and patients too ill to participate in trials spell trouble for the war against dementia. The degradation, struggle and cost in the UK (as well as America and elsewhere) will rise exponentially. The Daily...
Is the world ready for GV-971(Oligomannate)? Because the first new approved Alzheimer’s drug in many years is coming to a clinical trial near you. Conditionally approved by China’s regulators, many in the West are skeptical. However, industry sponsor Green Valley...
